The math of monopoly
The pharmaceutical industry operates on a paradox. A company spends a decade and $2.6 billion to invent a single molecule, […]
The math of monopoly Read Post »
The Math of Medicine: A Professional Guide to Biopharma Valuation
Why Traditional Valuation Fails in the Life Sciences Valuation in the life sciences deviates fundamentally from the rules governing software
The Math of Medicine: A Professional Guide to Biopharma Valuation Read Post »
How to Value a Life-Saving Drug Without Overpaying
The Disconnect Between Science and Spreadsheet Valuing a biotechnology or pharmaceutical company differs from evaluating a standard cash-flow-positive business. In
How to Value a Life-Saving Drug Without Overpaying Read Post »
Where are the Most Active U.S. District Courts for Drug Patent Litigation, Why, and What Does it Mean?
The geographic distribution of pharmaceutical patent litigation in the United States is currently undergoing its most significant realignment since the
Patent Infringement Liabilities and Regulatory Arbitrage in Pharmacy Compounding
Executive Strategic Analysis The pharmaceutical sector currently faces a structural conflict between two divergent regulatory and legal regimes: the intellectual
Patent Infringement Liabilities and Regulatory Arbitrage in Pharmacy Compounding Read Post »
The Playbook of Serial Patent Enforcement in Brand-Name Drug Defense
The End of the Binary Patent System The pharmaceutical industry has historically operated under a binary commercial model: a drug
The Playbook of Serial Patent Enforcement in Brand-Name Drug Defense Read Post »
Developing a Global Drug Patent Strategy: From Legal Documents to Competitive Advantage
The pharmaceutical industry operates on a foundation unlike any other. At its core, it is a high-stakes, capital-intensive ecosystem built
Developing a Global Drug Patent Strategy: From Legal Documents to Competitive Advantage Read Post »
Compounding vs. Patents: Can Innovation and Regulation Coexist?
The Unavoidable Collision: Compounding, Patents, and the Pursuit of Public Health A Strategic Crossroads The pharmaceutical landscape is a complex
Compounding vs. Patents: Can Innovation and Regulation Coexist? Read Post »
When One Lawsuit Isn’t Enough: Serial Patent Litigation and Its Impact on Generic Timelines
1. Executive Summary: The Structural Transformation of Exclusivity The pharmaceutical sector operates on a fundamental economic premise: the patent bargain.
